TP53 and small cell lung carcinoma: Eighty-seven percent (87%) of patients harbored ≥1 nonsilent somatic SNV in a DNA repair gene besides TP53 (S4 Table); similarly, within a Japanese SCLC study cohort in a previous study, 69% of patients were identified by the same criterion [5].